Frontiers in Public Health (Oct 2022)
Application of Internet-based multidisciplinary management in patients with genitourinary cancers in China: A brief introduction to a new model of healthcare service for cancer survivors during COVID-19 pandemic
- Yu Zhu,
- Yu Zhu,
- Yu Zhu,
- Yu Zhu,
- Shengming Jin,
- Shengming Jin,
- Shengming Jin,
- Shengming Jin,
- Hangcheng Fu,
- Hangcheng Fu,
- Hangcheng Fu,
- Hangcheng Fu,
- Hangcheng Fu,
- Hailiang Zhang,
- Hailiang Zhang,
- Hailiang Zhang,
- Hailiang Zhang,
- Xiaolin Lu,
- Xiaolin Lu,
- Xiaolin Lu,
- Xiaolin Lu,
- Chengyuan Gu,
- Chengyuan Gu,
- Chengyuan Gu,
- Chengyuan Gu,
- Weijie Gu,
- Weijie Gu,
- Weijie Gu,
- Weijie Gu,
- Fangning Wan,
- Fangning Wan,
- Fangning Wan,
- Fangning Wan,
- Weiyi Yang,
- Weiyi Yang,
- Weiyi Yang,
- Weiyi Yang,
- Xiaojian Qin,
- Xiaojian Qin,
- Xiaojian Qin,
- Xiaojian Qin,
- Dingwei Ye,
- Dingwei Ye,
- Dingwei Ye,
- Dingwei Ye
Affiliations
- Yu Zhu
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Yu Zhu
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Yu Zhu
- Fudan University Prostate Cancer Institution, Shanghai, China
- Yu Zhu
- Shanghai Genitourinary Cancer Institution, Shanghai, China
- Shengming Jin
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Shengming Jin
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Shengming Jin
- Fudan University Prostate Cancer Institution, Shanghai, China
- Shengming Jin
- Shanghai Genitourinary Cancer Institution, Shanghai, China
- Hangcheng Fu
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Hangcheng Fu
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Hangcheng Fu
- Fudan University Prostate Cancer Institution, Shanghai, China
- Hangcheng Fu
- Shanghai Genitourinary Cancer Institution, Shanghai, China
- Hangcheng Fu
- Department of Urology, University of Louisville, Louisville, KY, United States
- Hailiang Zhang
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Hailiang Zhang
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Hailiang Zhang
- Fudan University Prostate Cancer Institution, Shanghai, China
- Hailiang Zhang
- Shanghai Genitourinary Cancer Institution, Shanghai, China
- Xiaolin Lu
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Xiaolin Lu
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Xiaolin Lu
- Fudan University Prostate Cancer Institution, Shanghai, China
- Xiaolin Lu
- Shanghai Genitourinary Cancer Institution, Shanghai, China
- Chengyuan Gu
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Chengyuan Gu
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Chengyuan Gu
- Fudan University Prostate Cancer Institution, Shanghai, China
- Chengyuan Gu
- Shanghai Genitourinary Cancer Institution, Shanghai, China
- Weijie Gu
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Weijie Gu
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Weijie Gu
- Fudan University Prostate Cancer Institution, Shanghai, China
- Weijie Gu
- Shanghai Genitourinary Cancer Institution, Shanghai, China
- Fangning Wan
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Fangning Wan
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Fangning Wan
- Fudan University Prostate Cancer Institution, Shanghai, China
- Fangning Wan
- Shanghai Genitourinary Cancer Institution, Shanghai, China
- Weiyi Yang
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Weiyi Yang
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Weiyi Yang
- Fudan University Prostate Cancer Institution, Shanghai, China
- Weiyi Yang
- Shanghai Genitourinary Cancer Institution, Shanghai, China
- Xiaojian Qin
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Xiaojian Qin
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Xiaojian Qin
- Fudan University Prostate Cancer Institution, Shanghai, China
- Xiaojian Qin
- Shanghai Genitourinary Cancer Institution, Shanghai, China
- Dingwei Ye
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Dingwei Ye
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Dingwei Ye
- Fudan University Prostate Cancer Institution, Shanghai, China
- Dingwei Ye
- Shanghai Genitourinary Cancer Institution, Shanghai, China
- DOI
- https://doi.org/10.3389/fpubh.2022.952739
- Journal volume & issue
-
Vol. 10
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has triggered multiple global healthcare system crises. Apart from the pandemic itself, the travel restriction and social distance policy for the purpose of epidemic control has cast a shadow on the management of cancer survivors. Cancer survivors suffered a double blow from both the epidemic and cancer. To deal with the challenge, we explored a new Internet-based patient management model. This model has overcome the limitation of time and space and thus can help oncologists to provide remote multidisciplinary healthcare services for cancer survivors. These patients can get high-quality cancer management from multidisciplinary experts without too much transportation. This model has been applied in patients with genitourinary cancers and proved to be effective and efficient. Our study demonstrated that more patients benefited from this model during the pandemic of COVID-19, especially in those affected heavily by COVID-19. These results suggested that it can also give insight into the management of other cancer survivors in China. Given the long-term impact of the COVID-19 pandemic, we would like to introduce our new model of healthcare service and the application of Internet-based multidisciplinary management to our global peers and medical industries to help their cancer survivors who are delayed in treatment due to the COVID-19 pandemic.
Keywords
- Internet-based multidisciplinary management
- COVID-19 pandemic
- cancer survivors
- genitourinary cancers
- a new model of healthcare service
